Department of Pathology, Precision One Health
Director - Precision One Health Initiative, Professor of Systems Pharmacology
Dr. Jon P. Mochel obtained his Veterinary Medical Degree from the National Veterinary School of Alfort (Paris, France). He completed his Doctorate studying Neurosciences in collaboration with the College de France and received the Silver Medal from Paris XII for his work. Dr. Mochel holds a MS in Pharmacology and Pharmacokinetics and is a Diplomate of the European College of Veterinary Pharmacology and Toxicology (ECVPT). He completed his Ph.D at Leiden University (Netherlands), with a focus on the mathematical modeling of the cardiovascular system for optimization of ACE inhibitors dosing schedules in patients with congestive heart failure. He is a founder of the Animal Health Modeling & Simulation Society which aims at promoting the dissemination of mathematical modeling in Veterinary Sciences.
Dr. Mochel is a Professor of Systems Pharmacology in the Department of Pathology at the University of Georgia (UGA) and the Inaugural Director of the UGA Precision One Health Initiative. He is a Fellow of the American Academy of Veterinary Pharmacology and Therapeutics, and an ad hoc Study Section Reviewer for the US National Science Foundation, the National Institute of Standards and Technology, the UK Medical Research Council and the CNRS/INSERM ATIP-Avenir Program. He is currently the President of the European Association of Veterinary Pharmacology and Toxicology and the recipient of the 2022 Research Award from the American Academy of Veterinary Pharmacology and Therapeutics.
Dr. Mochel’s research pertains to the analysis of (pre)clinical data obtained from spontaneous animal models of human diseases to bridge the knowledge gap between experimental models and patients. He has authored more than 130 peer-reviewed publications in select biomedical journals and has attracted more than $17M research grants as lead PI or Co-Investigator. Jon is the co-founder of LifEngine Animal Health, a Y Combinator company developing gene editing solutions for canine oncology, and 3D Health Solutions, a platform for efficient drug screening in pharmaceutical research.